Sport

NBA Forward Brandon Clarke's Death Linked to Drug Effects

Los Angeles medical authorities report that Memphis Grizzlies forward Brandon Clarke's death resulted from the effects of heroin and cocaine.

10 August 2026Tagblick Newsdesk

Updated: 12 Aug 2026, 14:48AI-generatedWritten by an AI system, editorially responsible — how we work

Archive photo: NBA Forward Brandon Clarke's Death Linked to Drug Effects — Archive photoPhoto: NAPARAZZI · Flickr · BY-SA

Brandon Clarke, a forward for the Memphis Grizzlies, has died, with the Los Angeles medical authorities determining that his death was due to the effects of heroin and cocaine. This conclusion was reached following an investigation into the circumstances surrounding his passing.

Clarke was known for his contributions to the NBA and had garnered attention for his performances on the court. The announcement regarding the cause of death has drawn attention from both fans and the broader basketball community.

Authorities have not disclosed additional details regarding the timeline of Clarke's death or any potential investigations that may be ongoing in relation to this matter. Public reaction has been notably significant as fans process the news.

The legacy of Clarke within the sport continues to be discussed, as tributes and condolences pour in from various corners of the NBA community. Observers have expressed their sorrow over the loss, highlighting the impact he had during his career.

This item was written by an AI system on the basis of the headlines and short teasers of the independently operating newsrooms named below. We disclose this under Art. 50(4), second subparagraph, of Regulation (EU) 2024/1689 (AI Act). Before publication we check origin and verifiability — anything that appears in only one place is not published — as well as language, substance and legally sensitive content. No separate substantive review of each individual item by a natural person takes place; we therefore do not rely on the exemption in Art. 50(4), second subparagraph, of the AI Act. Editorial responsibility for this publication rests with the person named in the imprint (§ 18 Abs. 2 MStV). Please report errors to [email protected] — we will correct or remove the item. Full reports are available from the sources listed.